|
|
 |
|
|
|
|
|
20 year old Hispanic woman with bilateral blurry vision, nausea, weakness and severe headaches
Digital Journal of Ophthalmology 2005
Volume 11, Number 11
July 10, 2005
|
Printer Friendly
|
|
|
|
|
|
|
| References | Read RW. Vogt-Koyanagi-Harada disease. Ophthalmol Clin North Am 2002;15:333-41.
Snyder DA, Tessler HH. Vogt-Koyanagi-Harada syndrome. Am J Ophthalmol 1980;90:69-75.
Nussenblatt RB. Clinical studies of Vogt-Koyanagi-Harada's disease at the National Eye Institute, NIH, USA. Jpn J Ophthalmol 1988;32:330-3.
Rubsamen PE, Gass JD. Vogt-Koyanagi-Harada syndrome. Clinical course, therapy, and long-term visual outcome. Arch Ophthalmol 1991;109:682-7.
Ohno S, Minakawa R, Matsuda H. Clinical studies of Vogt-Koyanagi-Harada's disease. Jpn J Ophthalmol 1988;32:334-43.
Sasamoto Y, Ohno S, Matsuda H. Studies on corticosteroid therapy in Vogt-Koyanagi-Harada disease. Ophthalmologica 1990;201:162-7.
Read RW, Holland GN, Rao NA, Tabbara KF, Ohno S, Arellanes-Garcia L, Pivetti-Pezzi P, Tessler HH, Usui M. Revised diagnostic criteria for Vogt-Koyanagi-Harada disease: report of an international committee on nomenclature. Am J Ophthalmol 2001;131:647-52.
Kamondi A, Szegedi A, Papp A, Seres A, Szirmai I. Vogt-Koyanagi-Harada disease presenting initially as aseptic meningoencephalitis. Eur J Neurol 2000;7:719-22.
Goto H, Rao NA. Sympathetic ophthalmia and Vogt-Koyanagi-Harada syndrome. Int Ophthalmol Clin 1990;30:279-85.
Lubin JR, Ni C, Albert DM. Clinicopathological study of the Vogt-Koyanagi-Harada syndrome. Int Ophthalmol Clin 1982l;22:141-56.
Shindo Y, Inoko H, Yamamoto T, Ohno S. HLA-DRB1 typing of Vogt-Koyanagi-Harada's disease by PCR-RFLP and the strong association with DRB1*0405 and DRB1*0410. Br J Ophthalmol 1994;78:223-6.
Damico FM, Cunha-Neto E, Goldberg AC, Iwai LK Marin ML, Hammer J, Kalil J, Yamamoto JH. T cell recognition and cytokine profile induced by melanocyte epitopes in HLA-DRB1*0405-positive and -negative Vogt-Koyanagi-Harada uveitis patients. Invest Ophthalmol Vis Sci. [in press]2005.
Chan CC, Palestine AG, Nussenblatt RB, Roberge FG, Benezra D. Anti-retinal auto-antibodies in Vogt-Koyanagi-Harada syndrome, Behcet's disease, and sympathetic ophthalmia. Ophthalmology 1985;92:1025-8.
Moorthy RS, Inomata H, Rao NA. Vogt-Koyanagi-Harada syndrome. Surv Ophthalmol 1995;39:265-92.
Oshima Y, Harino S, Hara Y, Tano Y. Indocyanine green angiographic findings in Vogt-Koyanagi-Harada disease. Am J Ophthalmol 1996;122:58-66.
Read RW, VKH Therapy Group. Poster 2664: A retrospective multinational survey of current treatment patterns in acute and subacute Vogt-Koyanagi-Harada disease. 2004 Association for Research in Vision and Ophthalmology Annual Meeting. Fort Lauderdale, FL, April 25-29.
Paredes IP, Ahmed M, Foster CS. Poster 2663: Immunomodulatory therapy for VKH patients as a first line therapy. 2004 Association for Research in Vision and Ophthalmology Annual Meeting. Fort Lauderdale, FL, April 25-29.
Wakatsuki Y, Kogure M, Takahashi Y, Oguro Y. Combination therapy with cyclosporin A and steroid in severe case of Vogt-Koyanagi-Harada's disease. Jpn J Ophthalmol 1988;32:358-60.
Read RW, Rechodouni A, Butani N, Johnston R, LaBree LD, Smith RE, Rao NA. Complications and prognostic factors in Vogt-Koyanagi-Harada disease. Am J Ophthalmol 2001;131:599-606.
| |
|
|
|
|
|
|
Welcome, please sign in 
